F.D.A. Turmoil Keeps Spotlight on Its Commissionernews2025-12-19T16:11:23+00:00December 19th, 2025|The New York Times|
F.D.A. Names Agency Veteran to Run Drug Divisionnews2025-11-12T03:18:48+00:00November 12th, 2025|The New York Times|
How Ozempic Maker Novo Nordisk Lost Its Shinenews2025-08-07T13:33:20+00:00August 7th, 2025|The New York Times|
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warningnews2025-07-29T17:51:03+00:00July 29th, 2025|The New York Times|
What to Know About the Collapse of the F.D.A.news2025-07-08T09:01:49+00:00July 8th, 2025|The New York Times|
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugsnews2025-05-16T16:17:20+00:00May 16th, 2025|The New York Times|
Senators Press Marty Makary on Abortion Pills and Vaccinesnews2025-03-06T20:33:40+00:00March 6th, 2025|The New York Times|
FDA Nominee Marty Makary to Face Grilling Over Cutbacks and Policy Shiftsnews2025-03-06T10:02:40+00:00March 6th, 2025|The New York Times|
Dr. Oz: How His Millions Collide With Medicarenews2025-02-24T10:00:29+00:00February 24th, 2025|The New York Times|
